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Abstract
Background: Patients with atopic dermatitis benefit from treatment with crude 
coal tan We started a program for the treatment of patients with atopic derma­
titis in an out-patient facility using intermittent applications of crude coal tar. 
Objective: To study the efficacy and feasibility of an out-patient regimen using 
crude coal tar in atopic dermatitis. Methods: We treated 18 patients in the 
out-patient setting. A trained nurse and after thorough instruction the patients 
themselves at home applied crude coal tar in a zinc paste 2 or 3 times a week. 
We studied the improvement by visual scoring and compared the results with pa-
............................. *.......... tients treated with daily applications at the in-patient department Results: The
improvement was comparable at the end of the treatment period for both set- 
Oul-patient treatment tings. The treatment period, however, was longer for the patients treated in
Atopic dermatitis the out-patient setting. Conclusion: The out-patient programme proved to be
Crude coal tar an efficacious and a well-appreciated approach.
Crude coal tar has a history of many centuries in the it stains and smells. From a cosmetic point of view solutio
treatment of skin disorders. Already Hippocrates treated carbonis detergens is more popular as home treatment. The
patients with inflammatory skin conditions with tar prepa- efficacy of solutio carbonis detergens is inferior to the effi-
ratiotis |l|. cacy of crude coal tar [2|. An alternative for the in-patient
It is effect ivo in the treatment of chronic lesions in treatment of atopic dermatitis might be intermittent treat-
atopic dermatitis and may be a substitute for long-term ment with crude coal tar at the out-patient department. To
treatment with topical corticosteroids |2|. Coal tar is manu- the best of our knowledge, a comparative study between
factured as crude coal tar (pix lithantraeis) or as an alco- daily applications of crude coal tar (in-patient department)
holic extraction designated as solutio carbonis detergens, and intermittent applications (3 times per week at the out-
Although animal experiments and industrial exposure to patient department) has never been carried out. An effective
crude coal tar indicate that tar preparations have a careino- intermittent treatment with coal tar at the out-patient de-
genie potential [3-7|, clinical studies suggest that thera- partment obviously would be advantageous from a socio-
peutic applications are safe 18 -111. Other treatments such as economic point of view,
corticosteroids, cyclosporin and phototherapy are effective Recently, an intensive out-patient treatment programme 
to varying extent in atopic dermatitis, however side effects was developed which consists in daily treatment with crude 
limit the application of these treatments. coal tar 1.5-5% in zinc paste. During the first week a 
Crude coal tar is mainly used in an in-patient setting. At specially trained nursing staff carried out the applica­
tile out-patient department this treatment is less popular as tions, whilst instructing the patients. After the patients had
learned how to do it correctly themselves with the help of 
their partners, they carried out the treatments at home.Sec also paiic 1 ot this issue.
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However, once a week the treatment was carried out at the
4
out-patient department.
In the present study, clinical improvement and accept­
ability of the intensive out-patient schedule for intermittent 
tar treatments was compared with the in-patient treatment 
with daily applications of crude coal tar. In total, 37 patients 
were included for either (i) daily in-patient treatment with 
crude coal tar or (ii) intermittent out-patient treatment with 
crude coal tan Clinical improvement and patients’ accept­
ability were assessed by the same investigator in both pro­
tocols.
Table 1. Extent o f lesions
Patients and Methods
Treatment Protocols
The intensive out-patient tar treatment protocol was carried oui by 
a nursing staff, trained in these treatments. The patients visited the 
treatment unit 2 or 3 times weekly, depending on the degree of in­
volvement. Following the application of the tar preparation the skin 
was protected by Tubifast Bandages (Seton Health Care Group, Old­
ham, UK). After the patient had learned how to carry out the treat­
ments, she or he visited the unit once a week for treatment and instruc­
tion whilst the remaining applications were carried out by the patient 
at home. If the skin of the face was affected we applied clobetason bu- 
lyrate cream intermittently and solutio carbonis detergens 10% in 
equal parts of white petrolatum and lanetlewax cream. In the first 
week of treatment betametasone valerate cream was applied under­
neath the tar on very active lesions. If the skin was very dry solutio car­
bonis detergens 10% in equal parts white petrolatum and lanette wax 
was applied underneath the tar.
The in-patient tar treatment protocol was carried out by a vveli- 
trained nursing staff. Tar applications are carried out by the nurses. 
Again, following the application of the tar preparation Tubifast 
Bandages were applied, if active lesions were present topical corti­
costeroids were used during a few days.
Tar preparations consisted of crude coal tar 1.5-5% in zinc. In 
general, the concentration of coal tar was 5%. The concentration was 
reduced in case of irritation.
Number of 
patients
Costa score 
(range)
Costa score 
(median)
Costa score 
(mean ± SD)
Intensive
out-patient
treatment 18 25-65 46 44.3 ± 11.6
In-patient
treatment 19 34-79 50 49.8 ± 12.6
Evaluation of Treatment Results
Before treatment and at weekly intervals assessment of the sever­
ity scores were carried out by the same investigator using a scoring 
system simplified as suggested by Costa et al. 1131,
The system consists of 10 severity criteria (erythema, edema, vesi­
cles, crusts, excoriations, scaling, lichénification, depigmentation, 
pruritus and sleeplessness). The criteria were graded: 0 = absent; 
I = slight; 2 = moderate; 3 = severe. We scored 5 symmetrical areas 
(arms, hands, knees, legs and feet) and 4 asymmetrical areas (scalp, 
face, anterior aspect of the trunk and nates) according to the listed cri­
teria.
The extent of the lesions was graded: 0 = 0%; I ~ 1-25%; 2-
26-50%; 3 = 51-75%; 4 = 76-100%.
A total score for the severity criteria was calculated by adding up 
and multiplying by 2.
The extent of the lesions was calculated by adding up the scores of 
both symmetrical areas each and the scores of the asymmetrical areas. 
The final score was calculated by adding up the score for the severi I y 
criteria and the score for the extent of the lesions.
Statistical analysis of the scores was carried out using a non pa­
rametric test: Mann-Whitnev test. Correlation between C'osta scores 
before treatment and the treatment perititi was assessed using the 
Spearman's rank coefficient. p< 0.05 was ties ig nateci to be statistically 
significant.
}
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Results
Patients
Between October 1993 and July 1994 in total 37 patients with 
atopic dermatitis were included. Patients were selected older than 18 
years. We included 18 patients (mean age 25 years; 8 males and 10 
females) treated in the out-patient facility and 19 patients (mean age 
31; 3 males and 16 females) treated in the in-patient department. 
Patients fulfilled the diagnostic criteria according to Hanifin and 
Rajka [12], Patients with erythroderma or systemic treatment of their 
skin disease were excluded. All patients had not responded satisfacto­
rily to the usual out-patient treatments such as topical corticosteroids 
and tar preparations. The inclusion for the in-patient regimen and the 
intensified out-patient regimen was not at random. If patients were 
living at a large distance from our center they were more likely to be 
included for in-patient treatment. If patients had a demanding social 
life, in general these patients were more likely to be included for treat­
ment at the out-patient unit. Information concerning the extent of the 
lesions is listed in table 1.
For intensive out-patient treatment with tar and for in­
patient treatment 18 and 19 patients, respectively, were in­
cluded. Relatively more female patients were admitted at 
the in-patient department. No significant difference could 
be observed between the in-patient group and the out-pa­
tient group with respect to the Costa scores before treat­
ment.
In table 2 the percentage of patients with early with­
drawal are listed. Withdrawal type 1 was defined as an un­
satisfactorily response without significant improvement 
during 3 weeks. Withdrawal type U relates to patients who 
regarded the treatment unacceptable for personal reasons 
(e.g. too time-consuming). Three patients (18%) regarded
^  4L*.
this treatment as unacceptable.
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Table 2. Withdrawals during treatments
Type I withdrawal Type 11 withdrawal
n % n %
Intensive
out-patient
treatment
In-patient
treatment
0 0 
0 0
3 18 
0 0
Table 3. Total tre 
(mean ± SD)
at ment period and Costa scores after treatments
Total treatment 
period weeks
Average decreases 
of Cos tu scores
Intensive
out-patient treatment 
In-patient treatment
(i.l ± 1.5 
3.7 ± 1.0
29.5 ±9,5 
35.0 ± 10.9
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Fig. 1. Treatment periods required to reach 50-60% reduction, 
60-70% reduction, and >70% reduction of the Costa scores.
pairment of quality of life was experienced by 83 and 92%, 
respectively, of the patients at the out-patient unit. Table 4 
summarizes these aspects.
Table 4. KITecl i)l'treatment schedules on daily activities
Discontinuation Impairment Impairment
out-door activity of daily work of daily life
% patients days/week
% patients % patients
Intensive
out-patient
treatment 71 3.7 S3 92
In-palient
treatment 100
Discussion
Efficacy analysis of the protocols for intensive out-pa­
tient tar treatment and in-patient tar treatment revealed that 
both treatments were highly effective in patients with 
atopic dermatitis. The treatment periods before a moderate, 
pronounced and excellent improvement had been reached 
were comparable for both protocols, although the treatment 
periods tended to be longer at the intensive unit for out­
patient treatments. The total treatment periods, again, tended 
to be longer at the out-patient unit compared to the in-pa­
tient department. The longer duration can be explained by a 
The duration of treatments before a moderate (A Costa tapering-off period instituted in the out-patient department 
score between 50 and 60%), pronounced (A Costa score facility in order to avoid fast recurrences. The clinical im- 
between 60 and 70%-) and an excellent (A Costa score more provement at the end of the treatment was comparable for 
than 70%) response were reached, are summarized in fig- the two regimens. It is of interest that the intermittent tar 
ure I. No statistically significant difference could be shown applications (2-3 times per week) are not inferior to the 
between both treatment protocols. The total durations of the classical daily applications. The combined treatinent-ins- 
trealmenls are summarized in table 3. It can be seen that the truction programme proved to be a successful approach. No 
total treatment period was longer at the unit for intensified single patient discontinued treatment at the in-patient or 
out-patient treatment compared to the treatment period at out-patient unit due to inefficacy.
the in-patient department. The decrease of the Costa scores The intensified out-patient treatment protocol was well
during treatment was comparable for both treatment set- appreciated by the patients. After a stay of 1-2 h at the
tings, treatment unit, the patients returned to home or work and
At the unit for intensive out-patient treatment 71% of the following the instructions the patients were able to carry
patients were absent from their work for on average 3.7 out the treatments at home. However, 71% of the patients
days per week. Impairment of daily work at home and im- had to refrain from work or school lor on average 3.7 days
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per week. In 83% of the patients daily work at home or In conclusion, the efficacy of intermittent tar applica-
daily life was impaired. In 18% of the patients treatment tions at the intensive out-patient unit proved to be compara- 
had to be discontinued for personal reasons. Of course the ble with daily tar applications at the in-patient department, 
load of atopic dermatitis and the load of the treatment on In general, the patients felt that it was advantageous to be
daily life might be of relevance in this respect. treated at the out-patient unit. However, the severity of
As the present study is uncontrolled without at-random atopic dermatitis and/or the load of the tar treatment caused
allocation preselection might be a serious bias. However, a substantial impairment of daily life in a significant num-
the severity of atopic dermatitis was comparable for both ber of patients treated at the intensive treatment unit of die
the in-patient and the out-patient schedules. out-patient facility.
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